Indian Journal of Gynecologic Oncology
Scope & Guideline
Fostering collaboration in the fight against gynecologic cancers.
Introduction
Aims and Scopes
- Gynecological Oncology Research:
The journal publishes original research related to various gynecological cancers, including ovarian, cervical, and endometrial cancers, focusing on epidemiology, risk factors, and treatment outcomes. - Clinical Practices and Treatment Outcomes:
It highlights clinical studies assessing treatment modalities such as chemotherapy, radiotherapy, and surgical interventions, providing insights into their effectiveness and safety in treating gynecological malignancies. - Innovative Diagnostic Techniques:
The journal emphasizes advancements in diagnostic methods, including imaging techniques, biomarkers, and histopathological evaluations relevant to gynecologic cancers. - Patient Quality of Life and Psychosocial Aspects:
Research addressing the quality of life, mental health, and psychosocial issues faced by patients undergoing treatment for gynecological cancers is a critical focus area. - Emerging Trends in Cancer Management:
The journal explores novel approaches in cancer management, including fertility preservation, personalized medicine, and the use of new technologies in treatment.
Trending and Emerging
- Fertility Preservation Techniques:
There is a growing emphasis on research related to fertility preservation in cancer patients, reflecting increased awareness and advancements in reproductive technology. - Personalized Medicine and Genomics:
Emerging studies focus on the role of genetic markers and personalized treatment approaches in managing gynecological cancers, highlighting a trend towards tailored therapies. - Telemedicine and Remote Care:
The incorporation of telemedicine and remote monitoring in cancer care has gained attention, particularly in the context of the COVID-19 pandemic, indicating a shift in patient management strategies. - Palliative Care and Quality of Life:
An increasing number of studies are addressing palliative care approaches and their impact on the quality of life for patients suffering from advanced gynecological cancers. - Integration of Artificial Intelligence in Diagnosis:
Research exploring the application of artificial intelligence and machine learning in diagnosing and managing gynecological cancers is on the rise, indicating a technological shift in the field.
Declining or Waning
- Traditional Surgical Techniques:
There has been a noticeable decline in publications focused solely on traditional surgical techniques without the integration of newer methodologies or technologies. - Basic Epidemiological Studies:
The frequency of basic epidemiological studies focusing on cancer prevalence and incidence without deeper analysis or intervention strategies has decreased. - General Cancer Awareness Campaigns:
Although still relevant, papers focused solely on generic cancer awareness campaigns are becoming less frequent, with a shift towards more targeted and evidence-based interventions.
Similar Journals
GYNECOLOGIC AND OBSTETRIC INVESTIGATION
Advancing Women's Health Through Rigorous ResearchGYNECOLOGIC AND OBSTETRIC INVESTIGATION, published by KARGER, is an influential journal dedicated to advancing the fields of obstetrics and gynecology. With an ISSN of 0378-7346 and E-ISSN 1423-002X, this esteemed publication has been disseminating pivotal research since 1895 and continues to serve as an authoritative source through its convergence until 2024. Renowned for its rigorous adherence to academic standards, it stands in the Q2 category for both Obstetrics and Gynecology and Reproductive Medicine as of 2023, reflecting its quality and impact within the scientific community. With Scopus rankings highlighting its commendable positions—Rank #66 in Obstetrics and Gynecology and Rank #31 in Reproductive Medicine—it is an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of women’s health issues and innovative care practices. Despite not being an open-access journal, its contributions significantly influence current and future directions in clinical and translational research.
Reports of Practical Oncology and Radiotherapy
Empowering oncology with innovative, practical insights.Reports of Practical Oncology and Radiotherapy is a distinguished open-access journal dedicated to advancing the fields of oncology, radiotherapy, and cancer research. Published by VIA MEDICA since 2001, this journal serves as a critical platform for disseminating innovative research and practical findings that impact clinical practices and patient outcomes. With an emphasis on fostering collaboration and knowledge exchange among researchers, clinicians, and students, the journal has positioned itself within the Q3 and Q4 categories of renowned directories in oncology, radiology, and nuclear medicine as of 2023. Based in Gdansk, Poland, it provides unrestricted access to its articles, ensuring that crucial research reaches a wide audience. This dedication to open access reflects the journal's commitment to transparency and innovation in the fight against cancer, making it an invaluable resource in this vital field of study.
INTERNATIONAL JOURNAL OF HYPERTHERMIA
Innovating treatment through the power of heat.INTERNATIONAL JOURNAL OF HYPERTHERMIA, published by Taylor & Francis Ltd, is a leading peer-reviewed journal dedicated to advancing the field of hyperthermia and its applications in medical science, particularly within cancer research and related disciplines. With an ISSN of 0265-6736 and an E-ISSN of 1464-5157, this journal has been a vital resource since its establishment in 1985, offering a platform for innovative research and clinical applications aimed at improving treatment outcomes. The journal is recognized with a Q2 category ranking in several fields, including Cancer Research and Physiological Medicine, reflecting its significant contribution to scientific knowledge and clinical practices. Furthermore, it has been Open Access since 2019, ensuring that cutting-edge research is accessible to a global audience. By facilitating the exchange of ideas and fostering collaborations among researchers, professionals, and students, the INTERNATIONAL JOURNAL OF HYPERTHERMIA serves as an essential resource in the quest to exploit hyperthermia’s full potential in therapeutic settings.
JOURNAL OF GYNECOLOGIC SURGERY
Exploring the frontiers of gynecologic surgical techniques.The Journal of Gynecologic Surgery is a pivotal publication dedicated to the field of gynecologic surgery, contributing to the advancement of knowledge and practices since its inception in 1989. Published by Mary Ann Liebert, Inc., this journal serves as an essential resource for researchers, clinicians, and students involved in obstetrics and gynecology. With an ISSN of 1042-4067 and an E-ISSN of 1557-7724, it provides critical insights into surgical techniques, innovations, and outcomes relevant to women's health. Although it currently does not offer open access, the content is valuable for professionals seeking to enhance their clinical skills and academic understanding. In the 2023 Scopus rankings, it is placed in the Q4 quartile for both Obstetrics and Gynecology and Surgery, reflecting its niche yet impactful role in these fields. The journal's ongoing repository of knowledge ensures that it remains a significant platform for the dissemination of scholarly research and practical applications in gynecologic surgery.
Journal of Gynecologic Oncology
Empowering Innovation for Women's HealthThe Journal of Gynecologic Oncology, published by the Korean Society of Gynecology Oncology & Colposcopy, stands as a premier open access platform since 2011, dedicated to advancing the field of gynecologic oncology. With an ISSN of 2005-0380 and an E-ISSN of 2005-0399, this esteemed journal showcases high-quality research that drives innovation in treatment and care for women affected by gynecologic cancers. Based in South Korea, the journal spans an impressive timeline from 2009 to 2024 and holds a distinguished Q1 ranking in both Medicine (Miscellaneous) and Obstetrics and Gynecology, emphasizing its vital contributions to these fields. The journal is recognized for its rigorous peer-review process and is indexed in Scopus, with notable rankings of #35/209 and #128/404 in Obstetrics and Gynecology and Oncology respectively. As a vital resource for researchers, clinicians, and students alike, it aims to disseminate impactful findings that enhance patient care and foster collaboration across international boundaries.
Gynecologic Oncology
Advancing the Frontiers of Gynecologic Cancer ResearchGynecologic Oncology, an esteemed journal published by Academic Press Inc Elsevier Science, stands at the forefront of research in the domains of Obstetrics and Gynecology and Oncology. With an exceptional track record dating from 1972 to 2024, this journal has established itself as a vital resource for scholars and practitioners alike, boasting a remarkable Q1 ranking in both fields as of 2023. Gynecologic Oncology not only ranks #13 out of 209 in Obstetrics and Gynecology and #72 out of 404 in Oncology but also operates within the top percentiles of academic influence, with a 94th percentile in Obstetrics and Gynecology and an 82nd percentile in Oncology on Scopus. Although the journal does not currently offer open access, it remains crucial for disseminating original research, reviews, and advances in the management and treatment of gynecological cancers. Researchers and health professionals will find this journal indispensable for staying informed on the latest advancements and breakthroughs in this vital area of medicine, fostering a deeper understanding and potentially transforming patient care practices.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Elevating the standard of care with peer-reviewed discoveries.Urologic Oncology - Seminars and Original Investigations is a premier journal published by Elsevier Science Inc, dedicated to advancing the field of urologic oncology through high-quality, peer-reviewed research and insightful scholarly discussions. With an ISSN of 1078-1439 and an E-ISSN of 1873-2496, this journal has established itself as a vital resource for professionals, researchers, and students alike since its inception in 1995. Currently holding a Q2 ranking in Oncology and a prestigious Q1 in Urology for 2023, it ranks 28th out of 120 in Urology and 177th out of 404 in Oncology within Scopus, underscoring its relevance and impact in these critical fields. While the journal operates under a subscription model, it continues to deliver compelling and transformative research aimed at enhancing patient outcomes in urologic oncology. With a focus on innovative therapies, diagnostic advancements, and clinical trials, the journal contributes significantly to ongoing dialogue and development in urologic health care.
Bladder Cancer
Fostering innovation in the realm of urological oncology.Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
Pioneering Research for Women's Cancer CareEUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY is a pivotal publication in the field of gynecological oncology, dedicated to advancing research and clinical practices. Established in 1980 and published by MRE PRESS, this journal serves as a platform for disseminating high-quality research, reviews, and case studies pertaining to the diagnosis and treatment of gynecological cancers. Although the journal currently operates without an open access option, it remains a valuable resource for professionals seeking to stay abreast of the latest developments and findings within the field. The journal is indexed in both Scopus and other reputable databases, contributing significantly to the ongoing discourse in medicine with a particular focus on obstetrics, gynecology, and oncology, although it has seen a discontinuation in coverage by Scopus post-2021. With an emphasis on rigorous peer-review and scholarly integrity, the EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY continues to play an essential role in fostering knowledge and innovation among researchers, clinicians, and students committed to improving patient outcomes in gynecological health.
BMC GASTROENTEROLOGY
Your Gateway to Cutting-Edge Gastrointestinal DiscoveriesBMC Gastroenterology is a premier open-access journal published by BMC, dedicated to disseminating high-quality research in the field of gastroenterology. Established in 2001 and headquartered in the United Kingdom, this journal aims to enhance the understanding of gastrointestinal disorders through innovative research, reviews, and clinical studies. With an impressive impact factor and ranking within the Q2 category in gastroenterology and miscellaneous medicine for 2023, BMC Gastroenterology plays a critical role in advancing knowledge and practices in the field. The journal's commitment to open access ensures that researchers, professionals, and students worldwide can freely access and share vital findings and insights. Encouraging collaboration and knowledge transfer, BMC Gastroenterology is an essential resource for those dedicated to improving gastrointestinal health and outcomes.